Ibaraki, Japan

Yoshimitsu Nakajima

This inventor holds 1 USPTO granted patent. Top assignee: Klinge Pharma Gmbh. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimitsu Nakajima. Retrieved from https://idiyas.com/inventor/yoshimitsu-nakajima-7w51dwpo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshimitsu Nakajima: Innovator in Bone Disease Remedies

Introduction

Yoshimitsu Nakajima is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of bone diseases. His innovative approach has led to the development of a unique remedy that addresses critical health issues.

Latest Patents

Yoshimitsu Nakajima holds a patent for "Remedies for bone diseases," which comprises droloxifene or a salt thereof as the active ingredient. This patent represents a significant advancement in the treatment options available for patients suffering from bone-related ailments.

Career Highlights

Nakajima is associated with Klinge Pharma GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Kazuaki Niikura and Yoshitada Notsu, to further enhance the impact of his work. Their combined expertise contributes to the advancement of medical treatments.

Conclusion

Yoshimitsu Nakajima's contributions to the field of medicine, particularly through his patent for remedies for bone diseases, highlight his role as an influential inventor. His ongoing work at Klinge Pharma GmbH and collaborations with esteemed colleagues underscore his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…